Vitasora Health Limited (ASX:VHL)
Australia · Delayed Price · Currency is AUD 0.0140
+0.0010 (7.69%)
Sep 9, 2026, 3:44 PM AEST
Vitasora Health Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 3.06 | 0.39 | 0.76 | 0.15 | 1.22 |
Short-Term Investments | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Cash & Short-Term Investments | 3.08 | 0.42 | 0.79 | 0.17 | 1.25 |
Cash Growth | 635.02% | -47.01% | 353.12% | -85.98% | -84.45% |
Accounts Receivable | 1.09 | 1.51 | 0.23 | 0 | 0 |
Other Receivables | 0.55 | 0.24 | 0.24 | 0.04 | 0.05 |
Receivables | 1.65 | 1.75 | 0.47 | 0.05 | 0.05 |
Inventory | 2.66 | 2.88 | 2.75 | 2.62 | 2.65 |
Prepaid Expenses | 0.24 | 0.27 | 0.02 | 0.16 | 0.17 |
Other Current Assets | 0 | 0.01 | - | 0.01 | 0 |
Total Current Assets | 7.63 | 5.34 | 4.03 | 3 | 4.12 |
Property, Plant & Equipment | 0.01 | 0.06 | 0.12 | 0.18 | 0.08 |
Goodwill | 6.63 | 6.95 | 1.96 | - | - |
Other Intangible Assets | 4.57 | 5.46 | 0.08 | - | - |
Total Assets | 18.84 | 17.81 | 6.19 | 3.18 | 4.21 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 2.06 | 3.02 | 1.71 | 1.51 | 0.52 |
Accrued Expenses | 0.51 | 0.44 | 0.43 | 0.34 | 0.27 |
Current Portion of Leases | - | 0.06 | 0.06 | 0.03 | 0.07 |
Current Unearned Revenue | - | 0.02 | 0.05 | 0.06 | 0 |
Other Current Liabilities | 0.07 | 0.13 | 1.18 | 0.29 | 0.33 |
Total Current Liabilities | 2.64 | 3.66 | 3.43 | 2.24 | 1.2 |
Long-Term Leases | - | - | 0.06 | 0.12 | - |
Pension & Post-Retirement Benefits | 0.07 | 0.07 | 0.07 | - | - |
Total Liabilities | 2.71 | 3.74 | 3.55 | 2.35 | 1.2 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 176.31 | 162.92 | 140.55 | 132.1 | 128.84 |
Retained Earnings | -160.19 | -151.37 | -141.61 | -138.05 | -133.31 |
Comprehensive Income & Other | 0.02 | 2.52 | 3.7 | 6.78 | 7.48 |
Shareholders' Equity | 16.13 | 14.07 | 2.64 | 0.83 | 3.01 |
Total Liabilities & Equity | 18.84 | 17.81 | 6.19 | 3.18 | 4.21 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | - | 0.06 | 0.12 | 0.15 | 0.07 |
Net Cash (Debt) | 3.08 | 0.36 | 0.67 | 0.03 | 1.18 |
Net Cash Growth | 751.62% | -46.37% | 2545.04% | -97.83% | -85.06% |
Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Filing Date Shares Outstanding | 2,340 | 1,577 | 1,147 | 843.24 | 761.85 |
Total Common Shares Outstanding | 2,340 | 1,577 | 1,147 | 843.24 | 761.85 |
Working Capital | 5 | 1.67 | 0.61 | 0.77 | 2.93 |
Book Value Per Share | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
Tangible Book Value | 4.93 | 1.66 | 0.6 | 0.83 | 3.01 |
Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Machinery | - | - | - | 0.08 | 0.05 |